President Donald Trump has unveiled a new website, TrumpRx, which the White House says will help Americans find lower-priced prescription drugs. The announcement was made at the White House alongside Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz and National Design Studio Director Joe Gebbia. As reported by ABC News, press secretary Karoline Leavitt described the platform as a state-of-the-art tool for consumers seeking lower drug costs.
TrumpRx is not a direct seller of medications. Instead, Dr. Oz said the site is designed to provide transparency by linking consumers directly to pharmaceutical company websites, allowing them to view and pay the lowest available cash price without using insurance.
Oz emphasized that the government is not acting as a middleman. He said the platform allows any drug company to list prices, enabling users to compare costs in their area and purchase directly from the seller.
Cost fears are rising faster than confidence in solutions
The rollout comes as Americans report growing anxiety about healthcare affordability. A recent poll by a nonprofit health policy research organization found that two-thirds of U.S. adults are worried about paying for healthcare for their families, a concern that now outweighs fears about gas prices or groceries. Similar frustration over rising costs has surfaced in other policy debates, including criticism of the crypto bill’s ethics tied to broader affordability concerns.
More than half of respondents said they expect healthcare costs to become even less affordable over the next year. The same poll found widespread anger after Congress allowed enhanced Affordable Care Act tax credits to expire, contributing to 1.4 million fewer enrollments and deepening financial strain for many households.
TrumpRx is part of the administration’s broader “most favored nation” strategy, which aims to pressure drugmakers to charge U.S. consumers prices comparable to those in other countries. Trump first promoted the approach in September, when Pfizer agreed to lower prices on certain Medicaid drugs.
Since then, the administration has reached similar voluntary agreements with Eli Lilly and Novo Nordisk. Both companies reduced prices on select weight loss medications ahead of the TrumpRx launch, as pharmaceutical pricing remains under scrutiny amid wider geopolitical tensions, including recent warnings from China over global policy pressure.
The website also ties into the administration’s recently released “Great Healthcare Plan.” The proposal calls on Congress to codify the most favored nation pricing model and includes measures aimed at increasing transparency and reducing out-of-pocket costs, though policy analysts have noted the lack of detailed implementation plans.
The White House says the goal of TrumpRx is straightforward: help Americans save money on prescriptions. Whether the platform delivers meaningful relief remains to be seen, but healthcare affordability is clearly the financial issue weighing most heavily on voters right now.
Published: Feb 5, 2026 08:15 pm